Product
Group A and C Meningococcal Polysaccharide Vaccine
1 clinical trial
1 indication
Indication
Healthy PopulationClinical trial
A Single-center, Randomized, Blind, Positive Control Phase III Clinical Trial to Evaluate Immunogenicity and Safety of Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged From 6 Months to 5 YearsStatus: Active (not recruiting), Estimated PCD: 2024-08-30